Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...

DMARDs are often used to treat RA and inflammatory types of arthritis, such as ankylosing spondylitis, psoriatic arthritis ...

Psoriatic arthritis (PsA ... of cervical spine are features that differentiate axial PsA from ankylosing spondylitis. Standardized assessment of damage to axial joints in PsA may be performed ...

Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ...

The Department for Work and Pensions (DWP) has confirmed that over 1.1 million adults across Great Britain are now receiving ...

Czech National Bank increased its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 6.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The ...

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

For patients with psoriatic arthritis, switching directly from adalimumab to tofacitinib with no washout period presents no ...